Trexject® (a range of pre-filled methotrexate syringes) will be listed under the Pharmaceutical Benefits Scheme (PBS) from 1 April 2018 for those with severe rheumatoid arthritis or psoriasis.
According to the Victorian Model of Care for Osteoarthritis of the Hip and Knee, the prevalence of OA in Victoria alone will increase by 42% 0 by 2030.
In August 2017, the Council of Australian Governments (COAG) approved Australia’s new National Digital Health Strategy (the Strategy) entitled, ‘Safe, seamless and secure: evolving health and care to meet the needs of modern Australia‘.
The vaccine-style treatment, known as DEN-181, uses immunotherapy to treat the cause of this debilitating autoimmune disease.
Recently, the Australian Healthcare and Hospitals Association produced the report, Rheumatology nurses: adding value to arthritis care which was commissioned by Arthritis Australia.
With new codeine regulations on the horizon, we need to rethink pain management strategies to include drug-free alternatives.
MOVE muscle bone and joint health recently released the report 'Everybody Move: Improving outcomes in musculoskeletal health' which outlines how changes in approaches to treatment and care can save our healthcare system hundreds of millions of dollars.
Pharmaceutical company, Abbvie, recently announced the launch of a new symptom screener questionnaire, Dont Turn Your Back on Pain, designed to help those with unresolved chronic back pain discover the possible cause of their discomfort.
The collaboration will focus on research around the early detection and prevention of rheumatoid arthritis – a debilitating auto-immune condition that many of us know all too well!
It doesn’t matter if it is a big event (like a 50th birthday party) or meeting friends in a café - whenever an invitation comes up, or I consider planning something myself, my brain starts firing a long string of questions.